In brief
AMH—anti-Müllerian hormone—is a blood marker used to help assess ovarian reserve and likely response to ovarian stimulation. It is not a count of every remaining egg, an egg-quality score or a personal pregnancy countdown. Its value depends on the question you want answered.
This reference guide brings the test, the report and the possible next steps together. You may be learning about reproductive health, planning years ahead, considering egg freezing, trying to conceive or preparing for treatment. Those are different goals, and the same number should not automatically lead to the same plan.
We use familiar terms such as ovarian reserve and female fertility while recognising that the relevant anatomy can also apply to trans men and non-binary people. Explain your organs, hormone or surgical history and family-building plans so the discussion fits you.
Key takeaways
- AMH mainly informs ovarian-reserve and stimulation-response questions; it does not measure all stages of conception.
- Low, high and within-range results need the reporting laboratory’s units and method, age and clinical context.
- Regular periods and low AMH can coexist because cycle pattern and ovarian reserve answer different questions.
- A higher AMH is not always a better result; high values can be relevant to PCOS assessment or treatment-response planning.
- Changing results need comparison before conclusions. Hormonal contraception and laboratory differences can matter.
- Learning is a valid next step. Tests, consultations and a six-month programme are options for particular needs, not requirements for every reader.
What is AMH, and where does it come from?
In the ovaries, AMH is produced by cells surrounding small developing follicles. A follicle is the structure in which an egg develops. The blood measurement acts as a marker of the population of these small follicles; it does not directly inspect all the eggs in an ovary.
Ovarian reserve refers to egg quantity. Egg quality concerns an egg’s potential, after fertilisation, to contribute to a live birth. These concepts are related to reproductive ageing but are not interchangeable. A report about reserve cannot answer every question about the egg itself.
Start by keeping those words separate: reserve, ovulation, quality and pregnancy outcome. That small distinction helps you understand why two apparently reassuring tests can answer different questions, and why a lower AMH is information rather than an entire diagnosis.
When can an AMH test be useful?
AMH can be useful when estimating ovarian response before IVF or egg freezing. In that setting, the question is often how the ovaries may respond to stimulation, not whether pregnancy is possible without treatment. The result helps a clinician set expectations and consider the treatment plan alongside other findings.
If you are simply curious or planning ahead, clarify what you would do with either result before arranging testing. Would the information prompt a preservation discussion, help prepare for treatment, or only add a number you do not know how to use? Education can come first.
Testing should not depend on proving that you have struggled for a particular length of time. You can ask reproductive-health questions before trying for a baby. Equally, AMH should not be sold as a certificate of fertility or a promise that you can safely postpone your plans.
| Your question | Where AMH may help | What still needs its own discussion |
|---|---|---|
| Preparing for IVF | Expected ovarian response to stimulation | Age, history, sperm, embryos, treatment risks and preferences |
| Considering egg freezing | Discussion of likely response and egg yield | Age at freezing, possible future use, costs, consent and uncertainty |
| Trying to conceive | Reserve information when clinically relevant | Ovulation, sperm, anatomy, timing and duration of trying |
| Planning years ahead | An informed conversation about reserve and options | AMH cannot give a personal deadline or guarantee future fertility |
| Using donor or reciprocal treatment | The question for the person providing eggs | Carrying a pregnancy and consent are different assessments |
How is AMH tested, and do you need a particular cycle day?
AMH is measured in a blood sample. Ask the service what collection method is used, which laboratory analyses the sample and how the result will be explained. A finger-prick and a venous appointment can involve different practical instructions; follow the service’s actual collection guidance.
AMH is commonly assessed without the strict early-cycle timing used for some other hormones, although biological variation exists. If your panel also contains FSH, LH, oestradiol or other tests, the timing of those measurements may matter. Do not assume that the whole panel follows the AMH rule.
Tell the service about medicines, hormonal contraception, supplements, ovarian surgery and relevant treatment. Ask whether preparation is needed and whether any particular medicine affects interpretation. Do not stop a prescribed medicine or contraception solely to obtain a preferred number.
How to read your AMH report
Keep the complete report, including the date, numerical result, units, laboratory reference information and any interpretative comment. A message saying “low” or a screenshot of a colour bar leaves out information that may matter.
Reports may use pmol/L or ng/mL. A number in one unit cannot be directly compared with the same number in the other. Ask for a checked conversion or comparison rather than placing the raw values beside each other and assuming a change.
Read the label in context. A laboratory reference interval, an age-related distribution and a threshold used to predict stimulation response are different things. “Below range” needs an explanation of which range, why it was used and what decision it affects.
If the report has no clear comment, ask the provider for one. Useful interpretation should explain both what the result supports and what remains unknown, with a proportionate next step rather than a universal package of additional tests.
| Report item | Why it matters | A useful question |
|---|---|---|
| Date and age at testing | Provide context for comparison and planning | Is this result current enough for the decision? |
| Units | Prevent comparing unlike numbers | Are both reports in the same units? |
| Laboratory or assay | Methods may not be directly interchangeable | Can these results be reliably compared? |
| Reference information | A range is not a personal pregnancy probability | Is this age-related, laboratory-specific or for treatment response? |
| Medicines and recent treatment | May influence interpretation | Does my history change how you read this result? |
AMH levels by age: what does “normal” mean?
AMH generally changes across reproductive life, but there is substantial variation among people of the same age. A population range describes measurements in a group. It cannot tell you exactly how long you can wait, how many children you will have or whether an egg will form a healthy embryo.
There is no universal online chart that replaces the reporting laboratory and your clinical context. Before using an age chart, check its population, units, assay and purpose. A stimulation-response threshold should not be relabelled as a boundary between fertile and infertile.
Ask two separate questions: what does my reserve information suggest for the treatment or preservation decision, and what does my age mean for the broader reproductive plan? A reassuring AMH should not erase the age discussion, and a lower result should not turn into an unsupported deadline.
What does low AMH mean?
A lower AMH may indicate a smaller population of developing follicles and a lower response to ovarian stimulation. That can matter when considering how many eggs might be collected, the burden of treatment and the realistic options to discuss. It does not count every remaining egg or by itself establish the cause.
The next step is to establish what “low” means on your report and what question it changes. A clinician may consider ultrasound, menstrual history, previous ovarian response or other investigations where appropriate. Not everyone needs the same additional panel.
If treatment is being discussed, ask for an explanation of the likely range of outcomes, uncertainty and alternatives. A low result should not be used alone to promise that treatment will fail, insist that donor eggs are the only route or persuade you to buy an unproven reserve-boosting programme.
Can you get pregnant naturally with low AMH?
Yes, natural conception can occur with low AMH. A reserve marker is not a reliable standalone individual prediction of natural pregnancy. The question also involves ovulation, sperm, reproductive anatomy, timing, age and the circumstances of trying.
A prospective US study published in 2017 analysed 750 women aged 30–44 without a history of infertility who had been trying for three months or less. Low AMH did not identify a significantly lower probability of conception in that particular cohort. It does not establish that AMH is irrelevant to every patient or that everyone with low AMH should expect the same outcome.
Use research to understand the limits of the test, not to calculate your personal odds from somebody else’s population. If conception is unresolved, seek a joined-up assessment that includes the sperm source early. If you are not trying, the result does not by itself prove a hidden conception problem.
How can periods be regular when AMH is low?
Cycle pattern and ovarian reserve are different parts of reproductive biology. A regular cycle can coexist with a lower reserve marker. Having a period does not reveal the size of the follicle pool, and a lower AMH does not automatically mean that ovulation has stopped.
Record cycle length and any changes, pain, bleeding or other symptoms. If there is a genuine question about ovulation, ask which assessment answers it. Repeating AMH alone is not a way of confirming every stage of the cycle.
For conception, think beyond two boxes labelled “periods normal” and “AMH low”. ProFertility’s Fertility Dance connects signalling and ovulation, eggs, sperm, transport, fertilisation, the uterus, implantation and pregnancy maintenance. AMH informs only one part of that wider picture.
What does high AMH mean, and is it PCOS?
A higher AMH may be associated with a larger population of small follicles and a stronger stimulation response. It is not proof of excellent egg quality or a reason to assume that every stage of fertility is working.
The 2023 international PCOS guideline allows AMH to help define polycystic ovarian morphology in adults within the diagnostic pathway, but explicitly advises against using it as a single diagnostic test for PCOS. Symptoms, cycle pattern and the other relevant criteria still matter. AMH is not recommended for this diagnostic purpose in adolescents.
If your result is high, ask whether the clinical question concerns PCOS, treatment response or another context. For IVF or freezing, the clinic should explain how it considers response and safety. A high result should not be treated as a contest-winning fertility score.
AMH, IVF and stimulation response
IVF involves stimulating follicles, collecting eggs and developing embryos in the laboratory. AMH can support the first part of that planning: expectations about ovarian response. The actual response becomes clearer during treatment.
Separate the steps when discussing outcomes: follicles seen, eggs collected, mature eggs, fertilisation, embryos and live birth are different endpoints. A reserve result does not guarantee that every collected egg will mature, fertilise or lead to a baby.
Ask the clinic to explain how AMH fits with antral follicle count, age and any previous cycle. What would a lower or higher response change? Which safety checks and review points are planned? Medicines and stimulation decisions belong with the treating clinicians, not an online result calculator.
AMH and egg freezing: useful information, not a decision by itself
For egg freezing, reserve information can help discuss likely collection response. The HFEA stresses that freezing is not a guarantee of a future baby and that age and the uncertainty of later use deserve careful consideration.
Ask how the clinic estimates collection outcomes for your circumstances, whether more than one cycle might be discussed and what the total cost includes. Include medicines, storage, future thawing and treatment, cancellation policies and consent. A quoted egg number is not a promised number of children.
You may decide to freeze, wait, pursue another route or simply learn more. AMH cannot choose among those options for you. Medical preservation before potentially fertility-affecting treatment is time-sensitive; an elective testing discussion should not delay the treating team’s arrangements.
Why might AMH change between tests?
A change can reflect biology, age-related change, the measurement method or influences such as hormonal contraception. A prospective 2018 study examining AMH across three assay platforms demonstrated why biological and analytical variation need attention when comparing results.
First compare dates, units, laboratory methods and your medication or treatment history. Then ask whether the difference is meaningful for the current decision. A percentage drop without that context should not become a prediction of lost egg quality or an urgent personal countdown.
A repeat measurement can sometimes resolve a specific uncertainty, but repeated testing without a decision can create a cycle of worry. Agree what either result would change and which service takes responsibility for explaining it. Our related blog examines falling AMH in more detail.
Does hormonal contraception affect AMH?
Some hormonal contraception can suppress ovarian-reserve markers, including AMH. ASRM’s 2024 committee opinion explains that stopping contraception for an agreed interval may sometimes allow a more informative assessment. This is an interpretation issue; it does not mean the medicine has permanently removed eggs.
Whether to retest, when to do so and whether contraception should change depend on why you use it and the decision being made. Pain management, pregnancy prevention and other health needs remain relevant. Discuss any change with the prescriber.
Tell the clinic the name, duration and timing of use. Ask whether the current result is enough for planning or whether an agreed reassessment would alter the options. There is no reason to stop a medicine simply because somebody online reports a higher number afterwards.
Does low AMH mean menopause or premature ovarian insufficiency?
AMH alone cannot diagnose menopause or provide a reliable personal date for it. If periods have stopped or changed substantially, or there are relevant symptoms, the question needs clinical assessment rather than an AMH-based countdown.
The joint evidence-based premature ovarian insufficiency guideline published in 2025 advises against AMH as the primary diagnostic test for POI. It may help when the diagnosis is uncertain, but must be interpreted in clinical context. Routine AMH prediction of POI is not recommended because accuracy is insufficient.
Tell the clinician about your cycle, medicines, surgery, previous treatment and symptoms. Ask what needs investigation now. Do not assume that a very low AMH either proves a diagnosis or makes other assessment unnecessary.
Can you increase AMH or improve egg quality?
A higher repeat AMH is a changed measurement, not proof that new eggs have been created or that egg quality has improved. Before considering an intervention, ask which endpoint was studied: a laboratory marker, eggs retrieved, pregnancy or live birth.
General health support and action on relevant modifiable factors can be worthwhile without making an AMH increase the goal. Discuss nutrition, medicines, smoking or a known condition for their actual health and reproductive relevance. Do not turn a blood result into a competition with your earlier self.
Be cautious about products promising to rebuild reserve, reverse reproductive ageing or guarantee better eggs. Ask for evidence in people like you, possible harms, total costs and alternatives. Necessary clinical care should continue while any agreed improvement work takes place.
Using AMH in solo, same-sex, donor and trans family-building plans
Map who will provide eggs, who will provide sperm and who will carry a pregnancy. These may be different people. AMH concerns the relevant ovarian-reserve question; it does not rank two partners’ value, preferences or suitability to carry.
If donor eggs are being used, the recipient’s AMH does not describe the donor’s egg reserve. If reciprocal IVF is being considered, the egg provider and the person carrying need connected but distinct discussions. Consent, legal parenthood and counselling questions cannot be answered by a hormone result.
For trans and non-binary people, explain hormonal and surgical history and the practical or emotional needs around testing. Use anatomy and goals to guide the care, rather than a gender label or assumed relationship. Individual treatment plans need the relevant specialist team.
Your AMH appointment checklist
Write your goal in one sentence: “I want to learn about reserve”, “I am considering freezing”, “We are choosing a treatment route” or “I need to understand two different reports”. This keeps the conversation connected to your actual decision.
Bring full reports, dates, units and comments; a list of medicines and hormonal contraception; relevant cycle or symptom notes; and any ovarian surgery or treatment history. If sperm, a donor or a partner is involved, explain that route without assuming every person needs the same tests.
Ask: What does this result establish? What does it not establish? Is an ultrasound, repeat sample or another investigation relevant—and why? What would change after either result? How does age influence the plan independently of AMH?
Finish with practical ownership: who explains further findings, how the plan will be reviewed, what costs are involved and when you should seek earlier contact. A useful explanation should leave you with a decision or a question to resolve, rather than only a colour-coded result.
Choose the level of support that fits your question
ProFertility is an education, testing and care ecosystem. If you are learning, use the related Library guides and free HerStory membership. If testing could answer a useful reserve question, explore the testing information. A standalone consultation can help with a focused concern, preservation planning or interpretation.
Where possible barriers and modifiable factors call for structured follow-through, the six-month ProFertility Plan connects assessment, relevant targeted investigations, clinical review, tailored action and reviews. It is one option; a programme cannot guarantee pregnancy, restore reserve or replace necessary specialist treatment.
Your next step should match readiness and purpose. You may leave this guide better informed without buying anything. That is a worthwhile outcome too.
Related guidance and support
Related blog articles
Frequently asked questions
What is AMH?
Anti-Müllerian hormone is a blood marker used to help assess ovarian reserve and likely response to stimulation. It is not a direct count of every egg or an egg-quality score.
What is a normal AMH for my age?
Interpret the result using its laboratory units, method and reference information alongside age and the clinical question. There is no universal number that certifies fertility or supplies a personal deadline.
Can low AMH and regular periods happen together?
Yes. Ovarian reserve and cycle pattern answer different questions. A regular cycle can coexist with a lower reserve marker.
Does high AMH mean PCOS?
Not by itself. In adults, AMH may contribute to the PCOS diagnostic pathway, but must not be used as a single diagnostic test.
Do I need AMH on day 2 or 3?
AMH is commonly assessed without strict early-cycle timing, but other hormones in the same panel can have timing requirements. Follow the service’s actual instructions.
Does AMH tell me whether IVF will work?
It can help with expectations about ovarian response, but is not a standalone prediction of pregnancy or live birth. Age, previous response and the wider treatment picture matter.
Should I stop contraception before testing?
Do not change prescribed treatment solely because of this guide. Tell the prescriber and testing service what you use and agree whether any change or retest would be useful.
Can AMH tell me when menopause will happen?
It cannot provide a reliable personal menopause date. Cycle changes or suspected premature ovarian insufficiency need clinical assessment rather than AMH alone.
Can supplements rebuild ovarian reserve?
Do not interpret a higher AMH result as proof of new eggs or improved egg quality. Ask what outcomes any intervention has actually demonstrated and discuss relevant health support with a clinician.
Can I learn or test before trying for a baby?
Yes. Curiosity, future planning and preservation are valid reasons to ask questions. Decide what information would be useful; testing is not compulsory for learning.
Clinical sources
- ASRM: ovarian-reserve testing and interpretation, committee opinion (2020)
- Steiner et al.: biomarkers of reserve and natural conception, prospective US cohort; JAMA (2017)
- International evidence-based PCOS guideline recommendations (2023)
- ASRM: hormonal contraception in fertility treatments, committee opinion (2024)
- ESHRE/ASRM/CRE-WHiRL/IMS: premature ovarian insufficiency guideline (2025)
- HFEA: egg freezing factsheet, current page accessed 13 October 2026
- Bungum et al.: biological variability and AMH assay platforms, prospective cohort (2018)
- University Hospitals of North Midlands: AMH laboratory information, accessed 13 October 2026
Source check: 2026-10-13. This guide is educational and does not replace individual medical advice.